Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25840
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Srinivasan, Ashish | - |
dc.contributor.author | van Langenberg, Daniel | - |
dc.contributor.author | De Cruz, Peter P | - |
dc.date | 2021-02-11 | - |
dc.date.accessioned | 2021-02-16T01:07:05Z | - |
dc.date.available | 2021-02-16T01:07:05Z | - |
dc.date.issued | 2021-05 | - |
dc.identifier.citation | Inflammatory Bowel Diseases 2021; 27(6): e69 | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/25840 | - |
dc.language.iso | eng | - |
dc.subject | Crohn disease | en |
dc.subject | dose intensification | en |
dc.subject | loss of response | en |
dc.subject | ustekinumab | en |
dc.title | Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Inflammatory Bowel Diseases | en |
dc.identifier.affiliation | Monash University, Department of Medicine, Melbourne, Australia | en |
dc.identifier.affiliation | Medicine (University of Melbourne) | en |
dc.identifier.affiliation | Department of Gastroenterology, Eastern Health, Melbourne, Australia | en |
dc.identifier.affiliation | Gastroenterology and Hepatology | en |
dc.identifier.doi | 10.1093/ibd/izab018 | en |
dc.type.content | Text | en |
dc.identifier.pubmedid | 33570129 | - |
local.name.researcher | De Cruz, Peter P | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Gastroenterology and Hepatology | - |
crisitem.author.dept | Gastroenterology and Hepatology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.